Katie Kalvaitis
katiekalvaitis.bsky.social
Katie Kalvaitis
@katiekalvaitis.bsky.social
Medical journalist
@gohealio.bsky.social
This week, the FDA approved Foundayo, Eli Lilly's #orforglipron, a once-daily oral GLP-1 receptor agonist

💊 Orforglipron can be taken without food or water restrictions

Read @gohealio.bsky.social's initial coverage here:
www.healio.com/news/endocri...

More to come!
FDA approves Foundayo, an oral GLP-1, for adults with obesity
The FDA approved a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight with weight-related comorbidities, Eli Lilly announced.
www.healio.com
April 3, 2026 at 3:49 PM
Healio ended March on a high note - two major medical meetings, one weekend, a lot of coffee ☕

⚜️ American College of Cardiology #ACC26: www.healio.com/news/cardiol...
🗻 American Academy of Dermatology #AAD2026: www.healio.com/news/dermato...

@gohealio.bsky.social @accintouch.bsky.social
April 3, 2026 at 3:46 PM
⚜️ Coming at you live from New Orleans

See what’s making headlines at #ACC26 — follow Healio's live coverage

#CardioSky #MedSky @gohealio.bsky.social @accintouch.bsky.social

www.healio.com/news/cardiol...
March 30, 2026 at 3:07 AM
🫀Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD.

📑The 2026 Guideline on the Management of Dyslipidemia incorporates recent updates and the latest evidence.

🔟 Read the top 10 practice takeaways below.

@gohealio.bsky.social

www.healio.com/news/cardiol...
Top 10 practice takeaways from 2026 dyslipidemia guideline
Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety Ch...
www.healio.com
March 17, 2026 at 7:57 PM
Women with hypothyroidism receiving levothyroxine had similar CVD risk vs women without thyroid disease, according to a new study.

The findings should be "reassuring” for those who prescribe levothyroxine for women, researchers said.

@gohealio.bsky.social #CardioSky

www.healio.com/news/endocri...
Levothyroxine not linked to increased CVD risk for women with hypothyroidism
Women with hypothyroidism receiving levothyroxine treatment have similar cardiovascular disease risk as those without thyroid disease, according to data published in Thyroid. In an analysis of 2,647 w...
www.healio.com
March 12, 2026 at 3:49 PM
🫀 How does return to work following a holiday impact the heart?

A new study in @jamanetworkopen.com reports higher rates of out-of-hospital cardiac arrest the first day back to work after multiday holidays vs other workdays.

Read more below.

@gohealio.bsky.social

www.healio.com/news/cardiol...
Rates of cardiac arrest increase first workday after holiday
The rate of out-of-hospital cardiac arrest the first day back to work after multiday holidays was significantly higher compared with other workdays, according to data published in JAMA Network Open.Th...
www.healio.com
March 12, 2026 at 3:06 PM
New data show:

🚨 Heart attack deaths increased from 2011-2022 among young adults
🚨 The rise in in-hospital mortality after a first-time event disproportionately affected women aged 18-54

Read @gohealio.bsky.social's coverage of this @ahajournals.bsky.social study ⬇️

www.healio.com/news/cardiol...
In-hospital mortality after first heart attack higher in young women vs. men
In-hospital mortality was significantly higher for younger women vs. younger men after a first heart attack, with women receiving fewer cardiac procedures and having more nontraditional cardiovascular...
www.healio.com
March 6, 2026 at 8:00 PM
Reposted by Katie Kalvaitis
❓Can Ozempic treat inflammatory diseases❓

🎙️In the latest Beneath the Surface podcast, @joelgel.bsky.social talks with Fatima Cody Stanford, MD, and Philip Mease, MD, about the role of GLP-1s in dermatology, rheumatology and beyond.

Listen ⬇️

@gohealio.bsky.social

www.healio.com/news/dermato...
The emerging role of GLP-1s in inflammatory diseases
www.healio.com
March 6, 2026 at 1:37 PM
New research from #ISC26:

🤰Women with a prior ischemic stroke had 2x higher odds of having another stroke during or soon after pregnancy

These findings have implications for counseling and stroke prevention, researchers told @gohealio.bsky.social

Full article: www.healio.com/news/cardiol...
Prior stroke doubles risk for recurrent event during and after pregnancy
A prior history of ischemic stroke may signal higher risk for another stroke during pregnancy and in the early postpartum period, researchers reported at the International Stroke Conference.
www.healio.com
February 19, 2026 at 3:12 PM
Don't miss our latest Nourish to Flourish Q&A about:

🌱 benefits of home-grown produce for women
🌱 mindful eating
🌱 tips to incorporate home gardening

I do NOT have a green thumb, but I am inspired after reading this column!

#NourishtoFlourish

More Q&As: www.healio.com/news/endocri...
What are the benefits of growing fruits and vegetables at home?👩‍🌾🪴

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Stacey Woodson, MS, RDN, LDN, about how home gardening supports multiple dimensions of women’s health.

Read the Q&A on our website!

www.healio.com/news/endocri...
February 19, 2026 at 3:09 PM
Reposted by Katie Kalvaitis
It's #WearRedDay!

"The biggest issue in women's heart health is the same issue in men's heart health, which is that we have a lot of ways to prevent heart disease... and we're not using them," Ann Marie Navar, MD, PhD, told us.

Read the latest news in women's heart health via the link in our bio!❤️
February 6, 2026 at 3:23 PM
❤️ Every day through my work with @gohealio.bsky.social , I get to help spread the word about women's heart health

Check out:
🔺Q&A: What makes women's heart health different - and why is matters - www.healio.com/news/cardiol...
🔺Updates in Cardio-Obstetrics - www.healio.com/news/cardiol...
Q&A: What makes women’s heart health different – and why it matters
Heart disease remains the leading cause of death for women. Despite advancements in awareness and research, gaps remain in the diagnosis and treatment of cardiovascular disease in women.February is Am...
www.healio.com
February 6, 2026 at 10:41 PM
❤️ Wearing red today to shine a light on women's heart health

💃 Heart disease can affect women at any age
🤰 Women go through unique life events that impact their risk
❣️ Heart disease remains the leading cause of death for women in the US

@gohealio.bsky.social #WearRedDay @americanheart.bsky.social
February 6, 2026 at 10:38 PM
Reposted by Katie Kalvaitis
💊@fda.gov plans to send cease-and-desist letters to drug manufacturers with "deceptive ads" & aims to close the "adequate provision" loophole created in 1997, which could effectively remove drug ads from TV. 📺

Our @gohealio.bsky.social coverage is here ⬇️

www.healio.com/news/endocri...
FDA cracks down on ‘misleading’ direct-to-consumer pharmaceutical advertising
President Donald J. Trump signed a new memorandum that aims to crack down on “misleading” direct-to-consumer pharmaceutical advertisements. On Sept. 9, Trump issued a memorandum to HHS Sec...
www.healio.com
September 11, 2025 at 1:46 PM
The presence of cardiovascular risk factors may cause the heart to “age” faster than a person’s chronological age, and social determinants of health may exacerbate this heart age discordance

Read more ⬇️

@gohealio.bsky.social @jamacardiology.com

www.healio.com/news/cardiol...
Some people’s hearts age faster than they do
Presence of CV risk factors may cause the heart to “age” faster than a person’s chronological age, and social determinants of health may exacerbate this heart age discordance, resear...
www.healio.com
September 8, 2025 at 3:37 PM
Catch up on news from the European Society of Cardiology Congress:

🫀 Digitoxin for HFrEF
🫀 Beta-blockers after heart attack
🫀 New treatments for obstructive + nonobstructive HCM
🫀 Baxdrostat for resistant hypertension
🫀 + more

www.healio.com/news/cardiol...

#ESCCongress @gohealio.bsky.social
European Society of Cardiology
The latest news from the ESC Congress, with physician perspective, researcher interviews and clinician insight.
www.healio.com
September 8, 2025 at 3:27 PM
A new scientific statement from @hfsa.bsky.social and @aspcardio.bsky.social classifies heart failure as a preventable condition against which preventive strategies can be deployed decades before symptom onset

Read more ⬇️

#CardioSky @gohealio.bsky.social

www.healio.com/news/cardiol...
‘We can’t treat our way out’: Scientific statement emphasizes heart failure preventable
A scientific statement on prevention of heart failure, a relatively new concept, has been released.The statement from the Heart Failure Society of America and the American Society for Preventive Cardi...
www.healio.com
August 13, 2025 at 8:40 PM
Misinformation about cholesterol ‘widespread’ on TikTok

Read more ⬇️ about research presented at #ASPC2025 that highlights the extent of cholesterol-related misinformation on social media and suggestion to combat it

#CardioSky @aspcardio.bsky.social

www.healio.com/news/cardiol...
Misinformation about cholesterol ‘widespread’ on TikTok
BOSTON — Much of the health-related content about cholesterol on social media, in particular TikTok, is inaccurate, according to research presented at the American Society for Preventive Cardiol...
www.healio.com
August 8, 2025 at 2:24 PM
☕️ Healio is live in Boston for the
@aspcardio.bsky.social Congress on CVD Prevention

Stay tuned for the latest updates on prevention of heart disease and more!

#ASPC2025 #CardioSky @gohealio.bsky.social
August 1, 2025 at 1:54 PM
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal hormone therapy and how to better educate patients and health care professionals

Read coverage from @gohealio.bsky.social, with reaction from experts in the field

#Endosky #Medsky

www.healio.com/news/endocri...
FDA panel calls for label changes, more education on menopausal hormone therapy
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and health care professionals.
www.healio.com
July 22, 2025 at 4:45 PM
☕

@gohealio.bsky.social spoke with Dr. Gregory Marcus @ucsfhealth.bsky.social about the observed cardiovascular benefits and harms of coffee and recommendations for healthy consumption

#Cardsky #Medsky

www.healio.com/news/cardiol...
Q&A: Coffee may provide many heart-healthy benefits independent of caffeine
Drinking coffee may provide anti-inflammatory benefits leading to potential reductions in future risk for heart disease, according to a state-of-the-art review published in the European Heart Journal....
www.healio.com
July 22, 2025 at 4:41 PM
📰 #ENDO2025 may be over but Healio's coverage continues

Visit the link ⬇️ for the latest updates on:

📌 obesity drug benefits
📌 a new treatment for acromegaly
📌 once-monthly growth hormone therapy
📌 + more

@gohealio.bsky.social @reginaschaffer.bsky.social #Endosky

www.healio.com/news/endocri...
July 21, 2025 at 8:12 PM
May is #WomensHealthMonth

Don’t miss these @gohealio.bsky.social articles:

📌CV risk for women with autoimmune diseases: www.healio.com/news/cardiol...

📌Changes in moles during pregnancy: www.healio.com/news/dermato...

📌Eating plan when using GLP-1s for weight loss: www.healio.com/news/womens-...
Women with autoimmune disease face more death from heart disease than men
Fewer patients with autoimmune disease are dying due to cardiovascular disease, but women remain at higher risk vs. men, according to data published in Circulation: Cardiovascular Quality and Outcomes...
www.healio.com
May 30, 2025 at 5:46 PM
🔥Highlights from day 2 #ACC25

📌 ALPACA
📌 BHF PROTECT-TAVI
📌 FRESH-UP
📌 Evolut Low Risk at 5 years
📌 DapaTAVI
📌 ADVANCE
📌 & more

All Healio Cardiology Today coverage in the link below

www.healio.com/news/cardiol...

#CardioSky
American College of Cardiology
The latest news from the ACC Annual Scientific Session, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention, heart failure and more.
www.healio.com
March 31, 2025 at 12:29 AM
New data on lepodisiran presented at #ACC25:

📌 substantial reductions in lipoprotein(a) at 6 months and 1 year vs placebo in phase 2 ALPACA study

📌 drug will allow infrequent administration

📌 a cardiovascular outcomes trial is underway

More below

www.healio.com/news/cardiol...
Lepodisiran lowers Lp(a) substantially with infrequent administration
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more than 90 percentage points with a single 400-mg dose compared with placeb...
www.healio.com
March 30, 2025 at 7:54 PM